IP Verse

Fibrogen patent opposition analysis

Get complete Patent Opposition Report for Fibrogen

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Fibrogen

Explore patent oppositions filed by Fibrogen against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3357911Prolyl Hydroxylase Inhibitors And Methods Of UseAKEBIA THERAPEUTICSFeb 13, 2023

Latest patents of Fibrogen opposed by its competitors

Explore Fibrogen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2298301Nov 16, 2022Medicaments For Increasing Endogenous Erythropoietin (Epo)1
EP3470397Dec 29, 2021Crystalline Forms Of A Prolyl Hydroxylase Inhibitor3
EP3003284Feb 12, 2020Pharmaceutical Formulations Of A Hif Hydroxylase Inhibitor2
EP2324834May 8, 2019Methods Of Increasing Endogenous Erythropoietin (Epo)1
EP2872488Aug 22, 2018Crystalline Forms Of A Prolyl Hydroxylase Inhibitor3
EP2289531Jul 4, 2018Medicaments For Increasing Endogenous Erythropoietine (Epo)2
EP2322153Oct 8, 2014Use Of Hif Alpha Stabilizers For Enhancing Erythropoiesis4

Top competitors of Fibrogen